154 related articles for article (PubMed ID: 35054387)
1. Immunohistochemical Expression Patterns of CD45RO, p105/p50, JAK3, TOX, and IL-17 in Early-Stage Mycosis Fungoides.
Aladily TN; Abushunar T; Alhesa A; Alrawi R; Almaani N; Abdaljaleel M
Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054387
[TBL] [Abstract][Full Text] [Related]
2. TOX Outperforms FOXP3, CD4 and GATA3 in Histopathological Diagnosis of Early Mycosis Fungoides.
Ahmed MM; Hegazy AA; Embaby A; Nawwar EM; Hegazy SA; Ibrahim HM; Gobran MA
Turk Patoloji Derg; 2023; 39(1):15-22. PubMed ID: 35642346
[TBL] [Abstract][Full Text] [Related]
3. TOX acts an oncological role in mycosis fungoides.
Yu X; Luo Y; Liu J; Liu Y; Sun Q
PLoS One; 2015; 10(3):e0117479. PubMed ID: 25811617
[TBL] [Abstract][Full Text] [Related]
4. TOX expression and role in CTCL.
McGirt LY; Degesys CA; Johnson VE; Zic JA; Zwerner JP; Eischen CM
J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1497-502. PubMed ID: 27345620
[TBL] [Abstract][Full Text] [Related]
5. TOX expression in different subtypes of cutaneous lymphoma.
Morimura S; Sugaya M; Suga H; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Arch Dermatol Res; 2014 Nov; 306(9):843-9. PubMed ID: 25216799
[TBL] [Abstract][Full Text] [Related]
6. TOX, TWIST1, STAT4, and SATB1 protein expressions in early-stage mycosis fungoides.
Örnek S; Ozekinci S; Ipin T; Kocaturk E
J Cutan Pathol; 2024 Mar; 51(3):232-238. PubMed ID: 37932931
[TBL] [Abstract][Full Text] [Related]
7. TOX Expression in Mycosis Fungoides and Sezary Syndrome.
Pileri A; Cavicchi M; Bertuzzi C; Righi S; Zengarini C; Sabattini E; Roncador G; Agostinelli C
Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885488
[TBL] [Abstract][Full Text] [Related]
8. TOX expression in cutaneous T-cell lymphomas: an adjunctive diagnostic marker that is not tumour specific and not restricted to the CD4(+) CD8(-) phenotype.
Schrader AM; Jansen PM; Willemze R
Br J Dermatol; 2016 Aug; 175(2):382-6. PubMed ID: 26931394
[TBL] [Abstract][Full Text] [Related]
9. Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis.
Huang Y; Litvinov IV; Wang Y; Su MW; Tu P; Jiang X; Kupper TS; Dutz JP; Sasseville D; Zhou Y
Oncotarget; 2014 Jun; 5(12):4418-25. PubMed ID: 24947046
[TBL] [Abstract][Full Text] [Related]
10. Stage-related increase in PIM2 expression in mycosis fungoides.
Nielsen MH; Nielsen PR; Bzorek M; Eriksen JO; Wehkamp U; Lindahl LM; Woetmann A; Ødum N; Litman T; Gjerdrum LMR
APMIS; 2024 May; ():. PubMed ID: 38757234
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Validation of Anti-TOX Antibody for Early-Stage Mycosis Fungoides Through Digital Analysis of Tissue Samples.
Pinilla-Pagnon I; Rojo-López R; Coll-Orduña I; Nogales-Moro A; Chao-Crecente M
Am J Dermatopathol; 2024 Apr; 46(4):204-211. PubMed ID: 38457684
[TBL] [Abstract][Full Text] [Related]
12. IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF).
Willerslev-Olsen A; Litvinov IV; Fredholm SM; Petersen DL; Sibbesen NA; Gniadecki R; Zhang Q; Bonefeld CM; Wasik MA; Geisler C; Zhou Y; Woetmann A; Sasseville D; Krejsgaard T; Odum N
Cell Cycle; 2014; 13(8):1306-12. PubMed ID: 24621498
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
14. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
[TBL] [Abstract][Full Text] [Related]
15. Molecular markers of early-stage mycosis fungoides.
Zhang Y; Wang Y; Yu R; Huang Y; Su M; Xiao C; Martinka M; Dutz JP; Zhang X; Zheng Z; Zhou Y
J Invest Dermatol; 2012 Jun; 132(6):1698-706. PubMed ID: 22377759
[TBL] [Abstract][Full Text] [Related]
16. Erythrodermic CD4/CD8 Double-Negative Mycosis Fungoides: A Case Report.
Alnasser MA; AlKhawajah NM; AlQadri NG; Shadid AM; Alsaif FM
Case Rep Oncol; 2021; 14(1):256-261. PubMed ID: 33776713
[TBL] [Abstract][Full Text] [Related]
17. Defining the mimics and clinico-histological diagnosis criteria for mycosis fungoides to minimize misdiagnosis.
Kelati A; Gallouj S; Tahiri L; Harmouche T; Mernissi FZ
Int J Womens Dermatol; 2017 Jun; 3(2):100-106. PubMed ID: 28560304
[TBL] [Abstract][Full Text] [Related]
18. CADM1 is a diagnostic marker in early-stage mycosis fungoides: Multicenter study of 58 cases.
Yuki A; Shinkuma S; Hayashi R; Fujikawa H; Kato T; Homma E; Hamade Y; Onodera O; Matsuoka M; Shimizu H; Iwata H; Abe R
J Am Acad Dermatol; 2018 Dec; 79(6):1039-1046. PubMed ID: 29928911
[TBL] [Abstract][Full Text] [Related]
19. Low CD7 expression in benign and malignant cutaneous lymphocytic infiltrates: experience with an antibody reactive with paraffin-embedded tissue.
Murphy M; Fullen D; Carlson JA
Am J Dermatopathol; 2002 Feb; 24(1):6-16. PubMed ID: 11803274
[TBL] [Abstract][Full Text] [Related]
20. Papular mycosis fungoides: two new cases of a recently described clinicopathological variant of early mycosis fungoides.
Martorell-Calatayud A; Botella-Estrada R; Sanmartín-Jimenez O; Requena C; Guillén-Barona C; Sangüeza OP
J Cutan Pathol; 2010 Mar; 37(3):330-5. PubMed ID: 19737334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
